Purner MB - Search Results

1

Comparison of cobas human papillomavirus test results from primary versus secondary vials of PreservCyt specimens and evaluation of potential cross-contamination.

Rao A, Young S, Krevolin M, Sun R, Purner MB, Sharma A, Behrens CM. Rao A, et al. Among authors: purner mb. Cancer Cytopathol. 2012 Dec 25;120(6):380-9. doi: 10.1002/cncy.21213. Epub 2012 Jun 20. Cancer Cytopathol. 2012. PMID: 22718678 Free article.

2

A prospective, open-label safety and efficacy study of combination treatment with melphalan, arsenic trioxide, and ascorbic acid in patients with relapsed or refractory multiple myeloma.

Berenson JR, Swift RA, Ferretti D, Purner MB. Berenson JR, et al. Among authors: purner mb. Clin Lymphoma. 2004 Sep;5(2):130-4. doi: 10.3816/clm.2004.n.020. Clin Lymphoma. 2004. PMID: 15453931 Clinical Trial. No abstract available.

3

Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion.

Connick E, Schlichtemeier RL, Purner MB, Schneider KM, Anderson DM, MaWhinney S, Campbell TB, Kuritzkes DR, Douglas JM Jr, Judson FN, Schooley RT. Connick E, et al. Among authors: purner mb. J Infect Dis. 2001 Dec 1;184(11):1465-9. doi: 10.1086/324488. Epub 2001 Nov 13. J Infect Dis. 2001. PMID: 11709791

4

Stimulation of human T lymphocytes obtained from Toxoplasma gondii-seronegative persons by proteins derived from T. gondii.

Purner MB, Berens RL, Tomavo S, Lecordier L, Cesbron-Delauw MF, Kotzin BL, Curiel TJ. Purner MB, et al. J Infect Dis. 1998 Mar;177(3):746-53. doi: 10.1086/514216. J Infect Dis. 1998. PMID: 9498457

5

Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis.

Nash PB, Purner MB, Leon RP, Clarke P, Duke RC, Curiel TJ. Nash PB, et al. Among authors: purner mb. J Immunol. 1998 Feb 15;160(4):1824-30. J Immunol. 1998. PMID: 9469443

6

CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans.

Purner MB, Berens RL, Nash PB, van Linden A, Ross E, Kruse C, Krug EC, Curiel TJ. Purner MB, et al. Infect Immun. 1996 Oct;64(10):4330-8. doi: 10.1128/iai.64.10.4330-4338.1996. Infect Immun. 1996. PMID: 8926107 Free PMC article.

7

Cross-reactivity of human Toxoplasma-specific T cells: implications for development of a potential immunotherapeutic or vaccine.

Purner MB, Krug EC, Nash P, Cook DR, Berens RL, Curiel TJ. Purner MB, et al. J Infect Dis. 1995 Apr;171(4):984-91. doi: 10.1093/infdis/171.4.984. J Infect Dis. 1995. PMID: 7706828

8

Epstein-Barr virus-transformed B cells, a potentially convenient source of autologous antigen-presenting cells for the propagation of certain human cytotoxic T lymphocytes.

Purner MB, Berens RL, Krug EC, Curiel TJ. Purner MB, et al. Clin Diagn Lab Immunol. 1994 Nov;1(6):696-700. doi: 10.1128/cdli.1.6.696-700.1994. Clin Diagn Lab Immunol. 1994. PMID: 8556523 Free PMC article.

9

Gene therapy for B-cell lymphoma in a SCID mouse model using an immunoglobulin-regulated diphtheria toxin gene delivered by a novel adenovirus-polylysine conjugate.

Cook DR, Maxwell IH, Glode LM, Maxwell F, Stevens JO, Purner MB, Wagner E, Curiel DT, Curiel TJ. Cook DR, et al. Among authors: purner mb. Cancer Biother. 1994 Summer;9(2):131-41. doi: 10.1089/cbr.1994.9.131. Cancer Biother. 1994. PMID: 7812362

10

Cloned human CD4+ cytotoxic T lymphocytes specific for Toxoplasma gondii lyse tachyzoite-infected target cells.

Curiel TJ, Krug EC, Purner MB, Poignard P, Berens RL. Curiel TJ, et al. Among authors: purner mb. J Immunol. 1993 Aug 15;151(4):2024-31. J Immunol. 1993. PMID: 8102155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters